홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Diisopropylethylamine → 7-(3-ethyl-1,2,4-oxadiazol-5-yl)-1-(phenylsulfonyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine

HRID 2421897
노트
인쇄 미리보기

반응식

HRID 2421897 반응식
[C:1]1([S:7]([N:10]2[CH2:15][CH2:14][O:13][C:12]3[N:16]=[CH:17][C:18]([C:20](Cl)=[O:21])=[CH:19][C:11]2=3)(=[O:9])=[O:8])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.O[NH:24][C:25](=[NH:28])[CH2:26][CH3:27].CCN(C(C)C)C(C)C>C(Cl)Cl.C1COCC1.CCCC[N+](CCCC)(CCCC)CCCC.[F-]>[CH2:26]([C:25]1[N:28]=[C:20]([C:18]2[CH:17]=[N:16][C:12]3[O:13][CH2:14][CH2:15][N:10]([S:7]([C:1]4[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=4)(=[O:9])=[O:8])[C:11]=3[CH:19]=2)[O:21][N:24]=1)[CH3:27]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 3

HCID 81531DiisopropylethylamineHCID 578966591-(phenylsulfonyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine-7-carbonyl chlorideHCID 178458070HCID 178458070, 화합물

생성물 1

HCID 442428007-(3-ethyl-1,2,4-oxadiazol-5-yl)-1-(phenylsulfonyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine수율 64.4%

시약·촉매·용매 3

HCID 6344Dichloromethane
용매
HCID 8028Tetrahydrofuran용매2회
HCID 2724141Tetrabutylammonium Fluoride용매

실험 절차

To a solution of 1-(phenylsulfonyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine-7-carbonyl chloride (40 mg, 0.118 mmol; Example 1, Step 1) in DCM (2 mL) was added N-hydroxypropionimidamide (20.81 mg, 0.236 mmol) and DIPEA (50 μL, 0.286 mmol). The reaction was stirred at room temperature for 16 hours. LCMS analysis of the reaction mixture indicated consumption of starting material. The reaction mixture was treated with saturated aqueous NaHCO3 (10 mL) and extracted with EtOAc (3×10 mL). The combined organics were dried over anhydrous Na2SO4 and concentrated in vacuo. The resulting solid was diluted with THF (5 mL) and TBAF in THF (118 μL, 0.118 mmol) was added. The reaction was then stirred overnight. The reaction mixture was concentrated in vacuo and the resulting paste was purified by flash column chromatography using a gradient elution of hexanes with 30-100% EtOAc to provide 7-(3-ethyl-1,2,4-oxadiazol-5-yl)-1-(phenylsulfonyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine (29.7 mg, 0.076 mmol, 64.2% yield) as a white solid. LCMS (+ESI) m/z=373.0 [M+H]+; 1H-NMR (CDCl3) δ 8.87 (d, 1H), 8.77 (d, 1H), 7.71 (m, 2H), 7.63 (tt, 1H) 7.51 (m, 2H), 4.01 (m, 2H), 3.92 (m, 2H), 2.84 (q, 2H), 1.39 (t, 3H).

후처리

  1. customconsumption of starting material
  2. additionThe reaction mixture was treated with saturated aqueous NaHCO3 (10 mL)
  3. extractionextracted with EtOAc (3×10 mL)
  4. dry with materialThe combined organics were dried over anhydrous Na2SO4
  5. concentrationconcentrated in vacuo
  6. additionwas added
  7. stirringThe reaction was then stirred overnight
  8. concentrationThe reaction mixture was concentrated in vacuo
  9. customthe resulting paste was purified by flash column chromatography
  10. washa gradient elution of hexanes with 30-100% EtOAc

출처 및 근거

ORD 기록
ord-0e6e740a9e5543da87ce3b21c85fde6a
출처 데이터셋
uspto-grants-2011_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07960377B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트